Phio Pharmaceuticals EBITDA Margin Growth & History (PHIO)

Phio Pharmaceuticals's ebitda margin was −42,476.19% for fiscal 2019.

View full Phio Pharmaceuticals company overview

Phio Pharmaceuticals annual ebitda margin history

Phio Pharmaceuticals annual ebitda margin

Fiscal yearPeriod endedEBITDA marginChange (percentage points)
20192019-12-31−42,476.19%−37198.65 pp
20182018-12-31−5,277.54%+88002.46 pp
20172017-12-31−93,280.00%−46111.58 pp
20162016-12-31−47,168.42%−17286.07 pp
20152015-12-31−29,882.35%
20132013-12-31−5,225.56%+7999.18 pp
20122012-12-31−13,224.74%

Phio Pharmaceuticals ebitda margin trends

Between the periods ended 2012-12-31 and 2019-12-31, Phio Pharmaceuticals's ebitda margin decreased from −13,224.74% to −42,476.19%, a change of −29251.45 percentage points. The latest reported quarter, Q1 2019, shows −10,133.33%.

About the metric

What EBITDA margin means

EBITDA margin measures EBITDA as a percentage of revenue. It can help compare operating profitability over time, but it excludes capital intensity, financing costs, taxes, and other items and is generally unsuitable for financial companies.

Calculation and source

How EBITDA margin is calculated

TickerStat calculates EBITDA margin as EBITDA divided by positive reported revenue for the same fiscal period. Changes are shown in percentage points. Fiscal periods can differ from calendar years, so exact period-end dates are included.

Review Phio Pharmaceuticals source filings ↗

Community posts

It’s quiet here.

No posts about PHIO yet. Start the conversation.

Write the first post